Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Ozempic (semaglutide) is a brand-name prescription drug used to manage type 2 diabetes and lower the risk of kidney and heart complications in people with both diabetes and chronic kidney disease.

Earlier in 2025, the U.S. Food and Drug Administration (FDA) approved Ozempic® (semaglutide ... to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD).

Rybelsus (semaglutide) and Ozempic (semaglutide ... problems in adults with type 2 diabetes and cardiovascular disease • to help prevent kidney disease progression and heart-related death ...

Ozempic may worsen your condition. Additionally, there have been reports of acute (sudden) kidney injury and worsening of chronic kidney disease with Ozempic since the drug was made available on ...

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...

She is affiliated with the National Kidney Foundation and the Department of Veterans Affairs. For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar.

University of Pittsburgh Medical School researchers walk us through multiple approaches they’ve tried in the past, are currently using or plan to use in the future, as well as the significant ...

asthma and chronic kidney disease. In retrospect, the program’s fate was sealed in 2021 when its leaders applied for a renewal of their grant. It seemed pro forma. This was its eighth renewal.

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy ... cardiovascular disease (ASCVD) or chronic kidney disease (CKD).